Cardiology
- Eruptive xanthoma: Warning sign of systemic disease
Initial laboratory testing showed a triglyceride level of 5,742 mg/dL.
- Update in perioperative cardiac medicine
Risk assessment, risk reduction, antiplatelet therapy after stent placement, and bridging anticoagulation.
- The ABCs of managing systolic heart failure: Past, present, and future
Digitalis, diuretics, and bedrest have given way to neurohormonal blockade and physical rehabilitation.
- Evolution of heart failure management: Miles to go
Despite progress, too many patients still suffer, too many die too young, and the costs are still too great.
- Dual antiplatelet therapy for acute coronary syndromes: How long to continue?
After drug-eluting stent placement, at least 12 months of dual antiplatelet therapy is recommended. Would longer be better?
- Should patients with stable ischemic heart disease undergo revascularization?
The benefi t is much less clear for stable disease than for acute coronary syndromes.
- Blood pressure targets (March 2016)
Readers comment on the Systolic Blood Pressure Intervention Trial (March 2016).
- Premature ventricular contractions: Reassure or refer?
Many patients need only reassurance and do not need to see a cardiologist.